RESOURCE DEVELOPMENT AND KNOWLEDGE MANAGEMENT

About Us

Resource Development & Knowledge Management (RD & KM) department falls under the Directorate of Research and Development in KEMRI. The department has three divisions and one unit.

These are:

  1. Knowledge Centers and Dissemination Division (KCDD).
  2. Innovation Technology Transfer Division (ITTD).
  3. Library and Publications Division.
  4. Intellectual Property Right (IPR) Unit.

RD & KM department is responsible for strengthening institutional capacity in knowledge generation, translation, storage, dissemination and utilization to improve Evidence Informed Decision Making (EIDM) in human health practice, policy and programs.

Mission

To improve human health and quality of life through research, capacity building, innovation and service delivery.

Vision

To be a leading center of excellence in research for human health.

Objectives

  1. To strengthen Institutional research systems and process by developing knowledge management policy document, developing KEMRI research repository and databases.
  2. To build, strengthen and sustain a human and physical capacity to conduct, absorb and utilize health research outcome.
  3. To strengthen knowledge management through translation and communication of research data to inform health policy, strategies and practices.
  4. To strengthen product development and service delivery by embracing new technologies for product development.
  5. To strengthen Innovation and Technology Transfer Division to increase the quality of commercial products at least 95%.
  6. To identify, protect and ensure utilization of the Institutes intellectual assets towards commercialization of the institute research product and services through Intellectual Property Rights Unit.

KM Process Flow

KNOWLEDGE CENTERS AND DISSEMINATION DIVISION (KCDD)

KCDD is responsible for establishing mechanisms for generating, capturing, synthesizing, assessing, sharing, disseminating, accessing and utilizing knowledge to solve health challenges and support the development aspiration of the Nation.

Learn More

INNOVATION AND TECHNOLOGY TRANSFER DIVISION (ITTD)

One of the Innovation and Technology Transfer Division mandate to produce reliable, sustainable and cost-effective basic health diagnostic reagents/devices.

Learn More

LIBRARY AND PUBLICATIONS

The Library is responsible for providing reading, reference, research materials, online resources and other services to the KEMRI scientific staff, non-scientific staff, partners, postgraduate students of the KEMRI Graduate School program, students and individuals from other relevant institutions and networks for Health research, administration, teaching and learning.

Learn More

INTELLECTUAL PROPERTY RIGHT UNIT (IPR)

IPR is responsible for Managing and protecting Institutional data, innovations and intellectual property rights for academic and commercial benefit.

Learn More

Research Publications

Policy Briefs

POLICY BRIEFYEAR
Improving the Effectiveness of Kenya’s COVID-19 Control Measures: Lessons from a Rapid Systematic Review
Genomic surveillance detects local transmission of the global variants of concern in nine counties in Kenya July 2021
Explaining the Three Waves of the COVID-19 Transmission in Kenya using a Mathematical Model
Understanding the mortality impact of COVID-19 from a longitudinal surveillance study in Kilifi CountyJune 2021
Partial Sanger Sequence Analysis of SARS-CoV-2 Spike (S) Gene Detects the Delta SARSCoV-2 Variant of Concern In Bungoma, Nakuru and Nyamira CountiesJune 2021
Partial Sanger Sequence Analysis of SARS-CoV-2 Spike (S) Gene Detects the Delta SARSCoV-2 Variant of Concern In Homabay and Kakamega (Lurambi) PrisonsJune 2021
Partial Sanger Sequence Analysis of SARS-CoV-2 Spike (S) Gene Detects the Delta SARSCoV-2 Variant of Concern in Baringo, Migori and Nakuru Counties and the Alpha VOC in Nyamira countyJune 2021
Partial Sanger Sequence Analysis of SARS-CoV-2 Spike (S) Gene Detects the Delta and Alpha SARS-CoV-2 Variants of Concern for the First Time in Vihiga CountyJune 2021
How can we strengthen health systems to respond to everyday challenges? What considerations under Covid-19?June 2021
Genomic surveillance indicates dominance of local transmission of the global variants of concern in Kilifi, Taita Taveta and Mandera counties in KenyaJune 2021
The Alpha (B.1.1.7) variant of concern continues to predominate SARS-CoV-2 infections in KenyaJune 2021
Predominance of SARS-CoV-2 Variants of Concern, 501Y.V1 and 501Y.V2 at the Kenyan CoastApril 2021
Detection of SARS-CoV-2 variant 501Y.V2 at Lunga Lunga Border Point, Kwale CountyFebruary 2021
Projections of COVID-19 Cases and Deaths Following Schools Reopening January 2021
Detection of SARS-CoV-2 Variant 501Y.V2 (South African origin) in Coastal KenyaJanuary 2021
Sero-prevalence of SARS-CoV-2 among truck drivers in KenyaJanuary 2021
Detection of SARS-CoV-2 Variant 501Y.V2 (variant of concern) in Comoros IslandsJanuary 2021
Detection of SARS-CoV-2 Variant 501Y.V1 in Coastal KenyaJanuary 2021
COVID-19 in border Counties in Kenya: Challenges and opportunities to enhance community and Health System Response December 2020
What can Kenya Learn from other Country Responses to a COVID-19 Second Wave?October 2020
Reopening schools during the COVID-19 pandemic: A summary of strategies from other countriesOctober 2020
Status of the COVID-19 Pandemic in Kenya: Evidence from serological and clinical surveillance, and predictive modellingAugust 2020
An Assessment of Knowledge, Attitudes, Perception and Practice (KAPP) about COVID-19 among the Kenyan PopulationAugust 2020
What Does it Cost to Treat a COVID-19 Patient in Kenya?July 2020
Interpreting SARS-CoV-2 RT-PCR Test Results: Recommendations From Experiences and Lessons Learnt from the KEMRI-CGMRC/ KEMRI-Wellcome Trust Research Programme Laboratory in KilifJuly 2020
Regional Social and Epidemiological Vulnerability to COVID-19 in KenyaJune 2020
What is the role of testing in the COVID-19 pandemic?June 2020
Regional Social and Epidemiological Vulnerability to COVID-19 in KenyaJune 2020
What Medicines are Under Consideration for Treatment of COVID-19?April 2020
Detection of SARS-CoV-2 Variant 501Y.V2 (South African origin) in Coastal Kenya Policy
Projections of COVID-19 Cases and Deaths Following Schools Reopening
Sero-prevalence of SARS-CoV-2 among truck drivers in Kenya
SARS-CoV-2 genomic diversity in Kenya, June – October 2020
Status of the COVID-19 pandemic in Kenya: Evidence from national case-based surveillance, serosurveillance and hospital-based clinical surveillance
Genome sequencing of SARS-CoV-2 Policy Brief
Emergence of new SARS-CoV-2 Variants of Concern: Should Kenya Review its Port of Entry Requirements for International Travelers?
KEMRI PRIORITY SETTING BRIEF
EVERYDAY RESILIENCE KEY
Web_Ethical challenges in conducting embedded long term research
Recentralisation within decentralisation
LEARNING SITE BRIEF
UPTAKE OF NEW TUBERCULOSIS DIAGNOSTIC AND TREATMENT TOOLS
TWENDE Science Policy brief
Social cultural POLICY brief

Our Partners

Prof. Jennifer Akinyi Orwa

Deputy Director KM & RD

She is entrusted with the responsibility of overall leadership and coordination of standard structures for identification, synthesis, sharing and application of knowledge aimed at improving the use of research evidence to inform policy and practice. She envisions a Kenya with better health outcomes through improved decision making informed by high quality, relevant, accessible and up-to-date synthesized research evidence.

In addition, Prof. Orwa is a professor of pharmacy and Director, Cochrane Kenya.

Contact Us

Kenya Medical Research Institute

Resource Development and Knowledge Management

P.O. Box 54840 00200 Off Raila Odinga Way. Nairobi, Kenya.

Email: knowledgemanagement@kemri.go.ke